NSABP Members' Area   Password Protected - Access   Limited to NSABP Participating   Institutions Only NSABP Foundation, Inc. General NSABP Information   Financial Conflicts of      Interest Policy   Contact the NSABP   Employment Clinical Trials Information   Clinical Trials Overview   Protocol Chart   Never Say Lost Treatment Trials Information   Protocol B-51   Protocol B-52   Protocol B-53/S1207   Protocol B-55/BIG 6-13 Prevention Trials Information   Protocol P-1 - BCPT   Protocol P-2 - STAR To report problems, ask questions or make comments, please send e-mail to: Webmaster@nsabp.pitt.edu

Annotated Bibliography of NSABP Publications Validation of a Self-Reported Neurotoxicity Scale in Patients With Operable Colon Cancer Receiving Oxaliplatin. Kopec JA, Land SR, Cecchini RS, Ganz PA, Cella D, Costantino JP, Wieand HS, Smith RE, Kuebler JP, Wolmark N. J Supp Oncol. 2006;4(8):W1-W8. [Epub only] Abstract Standardized questionnaires are important tools for evaluating adverse effects associated with new cancer treatments. This randomized trial, which assessed the measurement properties of the modifed Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale, was conducted in a subsample of patients participating in the National Surgical Adjuvant Breast and Bowel Project Protocol C-07.